Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight ...

Drugs best known for helping people lose weight may also chip away at the proteins that define Alzheimer’s disease. A systematic review of 30 preclinical studies, published in April 2026 in Molecular ...

Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of the cost of brand-name competitors such as Wegovy and Ozempic.

As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must pair their growing promise with sharper monitoring, safer prescribing, and fairer access. GLP ...

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these ...

The FDA has spent much of 2025 issuing warnings about a single, recurring problem with GLP-1 weight loss drugs: patients and providers are getting the dose wrong on compounded versions, and the ...

Ro is a telehealth company that offers virtual consultations and prescriptions for various health concerns, including GLP-1 weight-loss medications. The Ro Body program includes a monthly membership ...

Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks of nausea, vomiting, and diarrhea. High-quality evidence ...

Tracking body composition — not just total weight — helps you see whether you’re losing fat or muscle while taking a glucagon-like peptide-1 (GLP-1) medication. Preserving muscle can support your ...